Eurofins Scientific SE is a global leader in biopharmaceutical and clinical testing services, with quotes ‘ERF.PA’. The current price of the company is 68.22, with a 0.72 increase from the previous close of 67.50 and a 1.07% increase in percentage terms. The day high was 68.40 and the day low was 67.22, while the year high was 100.50 and the year low 58.06 respectively.
The market capitalization (marketCap) of Eurofins Scientific SE for 3 February 2023 was 13,706,696,880 EUR (13 bln EUR), for 2 February 2023 it was 13,286,789,640 EUR (13 bln EUR) , and for 1 February 2023 it was 12,558,693,600 EUR (12 bln EUR). The average price over 50 days is 66.22 and 200 days is 70.79 respectively . The exchange rate used is EURONEXT , with a total volume traded at 352 504 shares per day and an average volume traded at 436 868 shares per day .
Overall we can conclude that Eurofins Scientific SE has had a positive financial performance over the past three months with increasing marketCap values according to the data provided . The current stock price is well below its year high which could be attractive to investors given future prospects of the company . Additionally , although there has been some decline in stock prices over 200-day period this may present further investment opportunities as prices are still much lower than their highs . Investors should however perform their own due diligence into any potential investments before committing funds accordingly .
